Ethics approval and consent to participate
Tumor tissue samples (self-blood negative control) of pan-cancer were subjected to NGS n a College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certified laboratory of 3D Medicines Inc. This study was conducted under the approval of the ethics committees of the hospitals and informed consents were obtained from patients.